CVS Caremark removed Zepbound (tirzepatide) from its Standard, Advanced Control, and Value formulariesthe ones used by most employersand has confirmed "no new GLP-1 formulary changes" for January 2026
2 Medication options include Wegovy (semaglutide) 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg injection and 1.5 mg, 4 mg, 9 mg, and 25 mg pills, with Wegovy (semaglutide) 7.2 mg injection coming soon
Designed for men who want natural-looking results, Dysport works quickly to create a smoother, more energized appearance without surgery or extended recovery time
Compared to the other trials investigating GLP-1RAs, the ELIXA trial included T2D patients with recent acute coronary syndrome (ACS), suggesting that perhaps their CV risk was too severe to demonstrate a simple decline in CV events via short-term pharmacological intervention
Most insurance plans deny obesity treatment claims
Stick to 250500 mg daily unless your healthcare provider advises otherwise